The Business Times

New Israeli law will enable medical cannabis export

Published Wed, Dec 26, 2018 · 03:46 PM

[JERUSALEM] Israeli lawmakers have given final approval to a law enabling farmers to export medical cannabis, parliament said Wednesday, a move expected to generate significant revenue for the state.

The law passed Tuesday conditions growing cannabis on a health ministry license, with police providing approval and monitoring growers and investors, according to its explanatory notes.

The medical cannabis export market was expected to generate the state income of a US$265 million per year.

Yoav Kisch of Prime Minister Benjamin Netanyahu's Likud party, who penned the law, noted its "huge economic potential" for the state and farmers, calling medical cannabis "a blessed product that eases the suffering of the sick".

There are currently eight companies in Israel growing medical cannabis, with many more awaiting to receive permission from the authorities, a statement from parliament read.

In 2016 Israel approved the use of medical cannabis, and last year the public security ministry partially decriminalised marijuana use, setting fines and treatment for initial use instead of criminal procedures.

Israeli producers were expected to begin exporting within six months, according to iCAN, an Israel-based firm promoting medical cannabis technologies.

iCAN CEO Saul Kaye called the law "long overdue but welcome".

"Israel, already the most advanced nation in cannabis R&D, will now be able to produce and market cannabis and cannabis-based products that will help millions of people suffering from illnesses," he said in a statement.

Nearly two dozen countries have legalised medical marijuana use.

AFP

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here